APOE and kidney disorder: Vcam1 facilitates leukocyte recruitment in renal diseases [65, 66], Apoe influences lipid metabolism and renal function risk [60, 67], and Cystatin C acts as a biomarker for renal function, indicating impaired kidney function when elevated [53, 68, 69].